Our Blogs
Expert analysis and market trends for savvy investors

PharmEasy (API Holdings): When Turnarounds in Unit Economics Meet Unlisted Valuations (Profitability Path & Comps)
FY24 reset, rights issue, comps & the road to EBITDA+. Trade PharmEasy unlisted shares and join UnlistedCorner’s Vendor system.
Read More
Orbis Financial: What a Mid-Size Custodian/Services Player Brings to a Portfolio
Orbis Financial is one of the home-grown securities services platforms in this stack, operating as a SEBI-registered custodian with adjacent offerings
Read More
Lock-In & Supply Dynamics: Impact on Post-Listing Performance
Learn how SEBI’s lock-in rules and upcoming share unlocks affect post-listing performance, index inclusion, and market flows.
Read More
Decoding DRHP Documents: A Retail Investor’s Step-by-Step Guide
Learn how to read a DRHP step by step revenue drivers, key financial ratios, promoter holdings, use of proceeds, risk factors so you invest smarter.
Read More
Managing Risk & Liquidity in Unlisted Portfolios: Best Practices for Investors
Learn strategies for managing risk and liquidity in unlisted portfolios, including capping single-name exposure, treating unlisted shares as long-term
Read More
Tata Capital’s IPO Prep: What Roadshows Mean for Today’s Unlisted Pricing (Valuation, Risks, Exit Windows)
The Tata Capital IPO is entering its most consequential phase. With global and domestic investor roadshows underway and an updated DRHP now on SEBI’s.
Read More
NSE (National Stock Exchange): Updated Valuation, DRHP Prospects & Exit Scenarios in 2025
NSE’s FY25 dividend, settlement progress with SEBI, and 2025 policy shifts—what they mean for unlisted pricing, DRHP odds, and exits
Read More
NSE AGM Record Date & Dividend: Reading the Tea Leaves for an NSE Pre-IPO Timeline (What It Could Mean for Holders)
NSE set a final dividend for FY25 and a mid-August record date. What do these signals mean for a 2025–26 IPO? Holder strategy from UnlistedCorner.
Read More
India’s Unlisted Boom: Is 2025 the Inflection Year? (Mint’s take + how retail should navigate)
Unlisted shares are in the spotlight in 2025. Here’s Mint’s view, what’s changed in tax & regulation, and a clear retail playbook from UnlistedCorner.
Read More
HDB Financial Services: From Unlisted Darling to Post-Listing Reality-Holding or Exiting?
It finally happened. HDB Financial Services (HDBFS)—once the unlisted market’s most coveted NBFC—went public in July 2025.
Read More
Care Health Insurance: How to Think About Insurer Valuations in the Unlisted Market (unit economics, solvency, claims ratios)
Decode Care Health’s unlisted pricing with a clean framework: GWP/NEP, ICR vs. CoR, solvency 1.5× rule, GST & IRDAI updates plus how to trade safely
Read More
Unlisted to Listed: What Swiggy’s Fast Entry Into Nifty Next 50 Signals for Pre-IPO Investors
Swiggy listed on the NSE/BSE on November 13, 2024. Less than five months later, it was added to the Nifty Next 50 effective March 28, 2025, after joining the Nifty 100 during the semi-annual index review. This rapid progression tells pre-IPO investors three things: (1) quality private companies can transition to large-cap club quickly, (2) early index inclusion can unlock passive fund demand and liquidity, and (3) robust pre-IPO positioning—including understanding lock-ins and valuation bands—can materially affect outcomes post listing.
Read More
Vikram Solar IPO: Does the Price Band (₹315–₹332) Make Its Unlisted Price Look Cheap—or Risky?
Vikram Solar is among India’s leading solar PV module manufacturers with ~4.5 GW installed capacity and a strong industry profile. The company has expanded capacity and improved profitability in FY25, reflecting a favorable operating cycle for domestic module makers.
Read More